Metabolism prostaglandin alpha Zellweger syndrome Peroxisomal beta-oxidation major importance vivo degradation prostaglandins humans vitro peroxisomal fraction rat liver homogenate capacity prostaglandins order relative importance peroxisomes conversion vivo prostaglandin alpha infant suffering Zellweger syndrome congenital disorder absence intact peroxisomes control compound healthy volunteers Urine SEP-PAK cartridge high-performance liquid chromatography Zellweger patient prostaglandin polar control major urinary metabolite control absent urine Zellweger patient major urinary prostaglandin Zellweger patient omega-oxidized acid major urinary prostaglandin control subjects chromatographic properties tetranor prostaglandin accordance data present results combination previous vitro data peroxisomal beta-oxidation major importance vivo chain shortening prostaglandins 